This webinar provides guidance on managing pharmacovigilance (PV) across Europe, focusing on balancing global consistency with country-specific requirements. Participants will learn to meet strict European timelines while working with lean teams and practical strategies to enhance oversight and execution.
Pharmacovigilance is a global responsibility, but for small and mid-sized companies, it often feels overwhelming. Limited teams, tight budgets, and the absence of local affiliates can make staying compliant a constant challenge.
In this session, we’ll show you how to do more with less:
Expect a practical, hands-on discussion packed with tools, quick wins, and coordination strategies you can use immediately. We’ll share real case studies of SMEs that have successfully aligned global PV systems with local regulations, passed inspections, and scaled seamlessly as their products and markets grew.
Whether you’re building your first global PV framework or streamlining an existing one, this webinar will give you the clarity, strategies, and tools to stay compliant without unnecessary complexity.
Whether it’s pharmacovigilance, medical device vigilance, or tailored safety consulting, our experts are here to guide you through every step. Let’s work together to ensure the highest standards of safety and compliance for your products.
Global Safety Solutions
向最优秀的人学习
Hear from industry experts who bring hands-on experience in building and optimizing pharmacovigilance systems across global and local settings.
Head of Drug Safety & Vigilance, QbD Group
Dr. Almudena del Castillo is a Medical Doctor and Specialist in Family and Community Medicine, with extensive expertise in pharmacovigilance within the pharmaceutical industry. She has a strong interest in regulatory affairs and drug safety, having held key roles at major pharmaceutical companies, including Pfizer. She later combined her scientific and business acumen at leading life sciences consultancies, including Pharmalex and PLG, where she served as VP of Sales and Business Development. Currently, Almudena is Global Division Head of Drug Safety and Vigilance at QbD Group, where she leads the development of globally focused solutions in safety, regulatory compliance, and strategic medical affairs.
Senior Team Lead Vigilance Division QbD Poland
Joanna holds a Master’s degree in Biotechnology and postgraduate qualifications in Industrial Pharmacy. Before moving into Pharmacovigilance, she built broad expertise across the pharmaceutical industry in areas such as Chemistry, Manufacturing and Controls (CMC), Regulatory Affairs, and Strategic Development where she also gained insights into Market Access principles. Today, Joanna is Senior Team Lead, Vigilance Division at QbD Poland, where she leverages her diverse background to strengthen and optimize Pharmacovigilance systems. Her unique combination of scientific, regulatory, and strategic experience allows her to bridge disciplines and drive the continuous improvement of drug safety practices.
Keep watching
点播网络研讨会Manage the risk of nitrosamines in the pharmaceutical industry. Watch our webinar on demand and learn about regulation and risk analysis from experts.
立即观看
点播网络研讨会This webinar offers a foundational understanding of Extractables and Leachables (E&L), highlighting their impact on drug safety and stability, and current regulatory frameworks. It covers toxicological assessments and best practices in study design, supported by real-world examples to navigate the complex landscape surrounding E&L.
立即观看
点播网络研讨会This webinar aims to explore the transformation of safety teams from reactive cost centers to proactive benefit drivers, emphasizing the importance of providing teams with the right tools & resources to gain actionable insights.
立即观看专家观点直达您的收件箱——选择您的兴趣。
绝无垃圾邮件。随时取消订阅。
